Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - AIM ImmunoTech Inc. | heb12311410ka.htm |
| EX-32.2 - EXHIBIT 32.2 - AIM ImmunoTech Inc. | exhibit322-20141.htm |
| EX-31.2 - EXHIBIT 31.2 - AIM ImmunoTech Inc. | exhibit312-20141.htm |
| EX-32.1 - EXHIBIT 32.1 - AIM ImmunoTech Inc. | exhibit321-20141.htm |
| EX-31.1 - EXHIBIT 31.1 - AIM ImmunoTech Inc. | exhibit311-20141.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Hemispherx Biopharma, Inc.
Philadelphia, Pennsylvania
We consent to the incorporation by reference in Registration Statements (No.s 333-160499, 333-57134, 118903 and 333-155528) on Form S-8 and Registration Statements (No.s 333-136187, 333-117178, 333-119017, 333-108645, 333-111135, 333-113796, 333-130008, 333-159856 and 333-151696) on Form S-3 of Hemispherx Biopharma, Inc. and Subsidiaries of our report dated March 19, 2015 relating to our audit of the consolidated financial statements which appears in this Annual Report on Form 10-K of Hemispherx Biopharma, Inc. for the year ended December 31, 2014.
/s/ McGladrey LLP
McGladrey LLP
Blue Bell, Pennsylvania
March 19, 2015